BML is a leading provider in the Japanese healthcare sector, specializing in clinical laboratory testing and medical diagnostics. The company supports hospitals and medical practices through precise laboratory analyses, state-of-the-art medical technology, and efficient healthcare IT solutions.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bml is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bml last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at 52.85 JPY.
Across its last 3 earnings reports, Bml stock moved by ±3.1% on average the following day. The largest reaction was -4.8% on 05/13/2026; 2 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.